These results confirmed the diagnosis of stage B2 Sézary syndrome/mycosis fungoides, defined as ≥1000/μL of CD4+/CD26– or CD4+/CD7– cells or other aberrant lymphocyte populations identified by flow cytometry.3 The gene discussed is CD4; the disease is Sezary syndrome.